Trials & Tribulations Removing barriers to cancer care in underserved communities October 29, 2021Vol.47 No.40By Dany Habr
Trials & Tribulations A FLASH flood of research relating to ultra-high dose rate radiation therapy October 22, 2021Vol.47 No.39By Constantinos Koumenis and Amit Maity
Trials & Tribulations Converting Cox hazard ratios with Cox-TEL to improve interpretation of drug efficacy in checkpoint inhibitor trials September 10, 2021Vol.47 No.33By Yu Shyr
Trials & Tribulations Rogue drug maker first inflates the price of lomustine, then says No to Medicare coverage July 16, 2021Vol.47 No.28By Henry S. Friedman and John D. Lee
Trials & Tribulations Annals of Unintended Consequences: How FDA regulations undermine the biosimilar marketplace and the BPCIA June 18, 2021Vol.47 No.24By Howard S. Hochster and Michael P. Kane
FreeTrials & Tribulations Precision oncology must evolve to address health disparities June 04, 2021Vol.47 No.22By Brandon Mahal and Jeffrey Venstrom
Trials & Tribulations It’s time to rethink clinical trials in a post-pandemic world May 14, 2021Vol.47 No.19By Dana Dornsife
Trials & Tribulations Best practices in preventing heartbreak:A look at a SWOG cancer control trial April 16, 2021Vol.47 No.15By Justin Floyd and Monika Leja
Trials & Tribulations Setting a research agenda on cannabis and cannabinoids: Updates from the NCI symposium April 09, 2021Vol.47 No.14By Dylan M. Zylla
FreeTrials & Tribulations City of Hope leads Cancer Patients Bill of Rights resolution, aimed at expanding access to unleash the full benefits of cancer care innovation February 19, 2021Vol.47 No.07By Harlan Levine and Joseph Alvarnas
